Role of DbXell in the Treatment of Subjects With Mildly Uncontrolled Type 2 Diabetes Mellitus

Inclusion Criteria: * Male or female subjects with age of 18-70 years Established type 2 diabetes mellitus as defined by the American Diabetes Association, but of duration less than 10 years. * Suboptimal glycemic control as judged by HbA1c over target but not more than 8.0%.Current medication of not more than 2 oral hypoglycemic agents. No current or past insulin or GLP1 therapy. * FPG ≤ 180 mg/dL * Hemoglobin level of ≥ 10.0 g/dL * Serum ALT ≤ 2.5 times upper limit of normal * Serum creatinine \< 1.5 times upper limit of normal Exclusion Criteria: * Female of childbearing potential * Subjects with symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or other symptomatic ischemic arterial diseases necessitating medical treatment * Uncontrolled hypertension (SBP \> 160 mmHg and/or DBP \> 100 mmHg) * History of renal and/or liver disease * History of or the presence of any clinical evidence of malignancies * Presence of exacerbation of chronic illnesses, severe and acute infections, complicated infections * Current treatment with systemic corticosteroids or herbal (alternative) medicines * Participation in any other intervention trial within 30 days prior to Screening